Update on the Management of Ped ...
A primary challenge in the management of pediatric chronic hepatitis B (CHB) is the lack of established child-specific guidelines. Treatment decisio ...
New and Evolving Management Par ...
Hepatitis-C induced liver failure is the leading indication for liver transplantation in the United States, and the burden of hepatitis C virus (HCV ...
Update on the Risk of Hepatocel ...
Chronic hepatitis B virus infection is an important cause of liver-related morbidity and mortality, with hepatocellular carcinoma being the most lif ...
Combination Therapy for Chronic ...
Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several ...
Ribavirin: How Does it Work and ...
Ribavirin is a synthetic guanosine analogue, which acts against hepatitis C virus (HCV) through several mechanisms that include 1) immune modulation ...
Hepatitis B Genotypes: Role of ...
Hepatitis B viral genotypes influence natural history, with genotype Cmore likely to develop hepatocellular carcinoma than genotype B, thus influenc ...
IL28B Polymorphisms as a Predic ...
Hepatitis C virus (HCV) is the most common cause of chronic liver disease in the United States. There are more than 170 million cases worldwide, and ...
IL28B: Implications for Therapy
Within the last 2 years, a number of Genome- Wide Association Studies (GWAS) have shown that single nucleotide polymorphisms (SNPs) in the interleuk ...
Management of Lower-Risk Myelod ...
Myelodysplastic syndromes (MDS) represent a spectrum of bone marrow failure with variable outcome. Patients with “lower-risk” disease have an expect ...
The Relevance of Iron Overload ...
Accumulation of excessive amounts of iron in vulnerable organs and tissues, together with elevated plasma and intracellular concentrations of reacti ...
Updates in Cytogenetics and Mol ...
Myelodysplastic syndromes (MDS) are clonal hematologic neoplasms that can result in cytopenias and increase the risk of leukemic transformation. The ...
What is the Best Frontline Ther ...
Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease with significant variation in disease progression, response to therapy, and surv ...
Late Effects of Childhood Leuke ...
As survival rates for children treated for childhood cancers become significantly better, the focus is increasingly on determining the late effects ...
Treatment of Newly Diagnosed My ...
Melphalan plus prednisone (MP) has long been considered the gold-standard treatment for elderly patients with newly diagnosed myeloma, and it still ...
Role of Tyrosine Kinase Inhibit ...
The Philadelphia chromosome is the most common cytogenetic abnormality found in adult patients diagnosed with acute lymphoblastic leukemia. The resu ...
Treatment of Newly Diagnosed Mu ...
Treatment of myeloma has changed significantly in the past decade as a result of better understanding of disease biology, more effective treatments, ...
New Drugs for Chronic Myelogeno ...
The introduction of tyrosine kinase inhibitors (TKIs) has changed the landscape of therapy for chronic myelogenous leukemia (CML). Once considered a ...
Can Low-Risk, Early-Stage Patie ...
Advances in the treatment of Hodgkin lymphoma since about 1970 have led to a remarkable improvement in the long-term outcomes of what was once cons ...
Predicting the Response of CML ...
As of 2011, the choice of tyrosine kinase inhibitor (TKI) for the patient with newly diagnosed chronic-phase chronic myelogenous leukemia (CP-CML) ...
The Role of Autologous Transpla ...
Between 80% and 90% of Hodgkin lymphoma (HL) patients can be cured with up-to-date combinedmodality treatments, but patients with disease refractory ...
In Search of CML Stem Cells’ De ...
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder that is characterized by the presence of a fusion oncogene, BCR-ABL, which en ...
The Unique Characteristics and ...
In recent decades, the prognosis of Hodgkin lymphoma has been substantially improved, but these successes have been restricted to younger patients a ...
Chronic Myelogenous Leukemia: M ...
Molecular monitoring is a key component of the management of patients with chronic myeloid leukemia. The current recommendation is that molecular mo ...
Primary Mediastinal Large B-Cel ...
In recent years, an overlap in biologic and clinical features has been identified between classic Hodgkin lymphoma (CHL) and primary mediastinal lar ...
Impact of Diabetes on Postinfar ...
Diabetes mellitus, the metabolic syndrome, and the underlying insulin resistance are increasingly associated with diastolic dysfunction and reduced ...